Difference between revisions of "Villin"
Jump to navigation
Jump to search
(→Positive: more) |
|||
| Line 4: | Line 4: | ||
*Small intestine adenocarcinoma ~67% of 30 cases.<ref name=pmid17951204>{{Cite journal | last1 = Zhang | first1 = MQ. | last2 = Lin | first2 = F. | last3 = Hui | first3 = P. | last4 = Chen | first4 = ZM. | last5 = Ritter | first5 = JH. | last6 = Wang | first6 = HL. | title = Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. | journal = Am J Clin Pathol | volume = 128 | issue = 5 | pages = 808-16 | month = Nov | year = 2007 | doi = 10.1309/JAF3KVGJHQCJ1QF9 | PMID = 17951204 }}</ref> | *Small intestine adenocarcinoma ~67% of 30 cases.<ref name=pmid17951204>{{Cite journal | last1 = Zhang | first1 = MQ. | last2 = Lin | first2 = F. | last3 = Hui | first3 = P. | last4 = Chen | first4 = ZM. | last5 = Ritter | first5 = JH. | last6 = Wang | first6 = HL. | title = Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. | journal = Am J Clin Pathol | volume = 128 | issue = 5 | pages = 808-16 | month = Nov | year = 2007 | doi = 10.1309/JAF3KVGJHQCJ1QF9 | PMID = 17951204 }}</ref> | ||
*[[Colorectal adenocarcinoma]] ~98% of 48 cases.<ref name=pmid17951204/> | *[[Colorectal adenocarcinoma]] ~98% of 48 cases.<ref name=pmid17951204/> | ||
*[[Esophageal adenocarcinoma]].<ref name=pmid9688144>{{Cite journal | last1 = Regalado | first1 = SP. | last2 = Nambu | first2 = Y. | last3 = Iannettoni | first3 = MD. | last4 = Orringer | first4 = MB. | last5 = Beer | first5 = DG. | title = Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. | journal = Mol Carcinog | volume = 22 | issue = 3 | pages = 182-9 | month = Jul | year = 1998 | doi = | PMID = 9688144 }}</ref> | *[[Esophageal adenocarcinoma]] ~75% of 8 cases.<ref name=pmid9688144>{{Cite journal | last1 = Regalado | first1 = SP. | last2 = Nambu | first2 = Y. | last3 = Iannettoni | first3 = MD. | last4 = Orringer | first4 = MB. | last5 = Beer | first5 = DG. | title = Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. | journal = Mol Carcinog | volume = 22 | issue = 3 | pages = 182-9 | month = Jul | year = 1998 | doi = | PMID = 9688144 }}</ref> | ||
*[[gastric adenocarcinoma|Gastric cardia adenocarcinoma]] ~80% of 16 cases.<ref name=pmid9688144/> | |||
==See also== | ==See also== | ||
Latest revision as of 14:46, 25 November 2019
Villin is an immunostain that markers small and large bowel.
Positive
- Small intestine adenocarcinoma ~67% of 30 cases.[1]
- Colorectal adenocarcinoma ~98% of 48 cases.[1]
- Esophageal adenocarcinoma ~75% of 8 cases.[2]
- Gastric cardia adenocarcinoma ~80% of 16 cases.[2]
See also
References
- ↑ 1.0 1.1 Zhang, MQ.; Lin, F.; Hui, P.; Chen, ZM.; Ritter, JH.; Wang, HL. (Nov 2007). "Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma.". Am J Clin Pathol 128 (5): 808-16. doi:10.1309/JAF3KVGJHQCJ1QF9. PMID 17951204.
- ↑ 2.0 2.1 Regalado, SP.; Nambu, Y.; Iannettoni, MD.; Orringer, MB.; Beer, DG. (Jul 1998). "Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.". Mol Carcinog 22 (3): 182-9. PMID 9688144.